StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
19
Publishing Date
2023 - 03 - 10
1
2022 - 12 - 21
1
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 16
1
2021 - 07 - 12
1
2021 - 07 - 09
1
2021 - 07 - 01
1
2021 - 06 - 16
1
2021 - 06 - 11
2
2021 - 06 - 09
1
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 05
1
2021 - 04 - 23
3
Sector
Health technology
19
Tags
Adct-601
1
Agreement
5
Alliances
4
Antibody
2
Application
2
Approval
19
Approved
1
Association
2
Biomarkers
1
Biopharma
5
Bioscience
1
Biotech
1
Biotechnology
7
Breast
1
Business
4
Cancer
16
Care
2
Ceo
1
China
4
Clinical-trials-phase-i
3
Clinical-trials-phase-ii
2
Commercialization
3
Conference
28
Drug
3
Earnings
11
Europe
23
Events
16
Fda
3
Financial
14
Financial results
10
Global
3
Grant
2
Granted
2
Grants
2
Health
3
Lancet
2
License
6
Market
5
Meeting
5
N/a
59
People
7
Pharmaceutical
2
Phase 1
2
Phase 2
7
Phase 2b
2
Phase 3
3
Platform
2
Presentation
6
Product-news
3
Report
3
Research
9
Results
34
Solid tumors
2
T-cell
5
Therapeutics
82
Treatment
5
Trial
15
Update
2
Year
3
Zynlonta
17
Entities
Abbott laboratories
24
Abbvie inc.
37
Adc therapeutics sa
19
Adma biologics inc
17
Agios pharmaceuticals, inc.
11
Allied corp.
7
Alnylam pharmaceuticals, inc.
13
Alvotech lux holdings s.a.s.
7
Amgen inc.
22
Amneal pharmaceuticals, inc.
15
Amphastar pharmaceuticals, inc.
9
Ani pharmaceuticals, inc.
17
Argenx se
10
Arrival
14
Atlanticus holdings corporation
8
Aveo pharmaceuticals, inc.
20
Bausch health companies inc.
8
Beigene, ltd.
25
Biocryst pharmaceuticals, inc.
16
Biogen inc.
20
Blueprint medicines corporation
23
Boston scientific corporation
8
Bristol-myers squibb company
48
Calliditas therapeutics ab
8
Clovis oncology, inc.
19
Cns pharmaceuticals, inc.
11
Eli lilly and company
46
Epizyme, inc.
18
Exelixis, inc.
14
Franchise group, inc.
15
Gilead sciences, inc.
16
Glaxosmithkline plc
10
Guardant health, inc.
12
Halozyme therapeutics, inc.
9
I-mab
8
Illumina, inc.
12
Incyte corporation
41
Jaguar health, inc.
8
Jazz pharmaceuticals plc
8
Johnson & johnson
94
Kamada ltd.
11
Karyopharm therapeutics inc.
31
Lithium corp
11
Medtronic plc
28
Merck & company, inc.
8
Novartis ag
21
Novavax, inc.
10
Orange
21
Perrigo company
21
Pfizer, inc.
31
Reata pharmaceuticals, inc.
9
Regeneron pharmaceuticals, inc.
32
Rigel pharmaceuticals, inc.
11
Sanofi
97
Takeda pharmaceutical company limited
20
Teva pharmaceutical industries ltd
13
Verastem, inc.
10
Vertex pharmaceuticals incorporated
8
Viatris inc.
8
Y-mabs therapeutics, inc.
19
Symbols
ABBV
6
ADCT
19
AGIO
5
ALNY
5
AMGN
6
AVEO
13
BGNE
5
BMY
13
BPMC
13
CLVS
13
CTIC
1
EPZM
13
EXEL
5
GLAXF
1
GSK
1
ILMN
5
INCY
13
KPTI
13
LLY
13
NVS
1
NVSEF
1
PFE
5
REGN
13
RIGL
5
SNY
13
TEVJF
1
VSTM
5
YMAB
13
Exchanges
Nasdaq
14
Nyse
19
Crawled Date
2023 - 03 - 10
1
2022 - 12 - 21
1
2021 - 07 - 27
1
2021 - 07 - 22
1
2021 - 07 - 16
1
2021 - 07 - 13
1
2021 - 07 - 09
1
2021 - 07 - 01
1
2021 - 06 - 16
1
2021 - 06 - 11
2
2021 - 06 - 09
1
2021 - 05 - 28
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 05
1
2021 - 04 - 23
3
Crawled Time
00:01
1
09:00
1
11:36
1
12:00
1
12:43
1
13:13
1
14:58
1
18:17
1
18:26
1
18:31
2
18:33
1
18:42
2
19:11
1
19:32
1
19:52
1
23:00
2
Source
www.biospace.com
3
www.fda.gov
15
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Approval
entities :
Adc therapeutics sa
save search
Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio
Published:
2023-03-10
(Crawled : 23:00)
- prnewswire.com
AMGN
|
News
|
$274.12
0.81%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
CTIC
|
$9.09
0.05%
11M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.305
630
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.16
0.76%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$95.11
490
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$97.25
2.24%
2.6M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.165
1.42%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
Email alert
Add to watchlist
approval
therapeutics
growth
market
ADC Therapeutics and Sobi Announce European Commission Approval of ZYNLONTA® (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Published:
2022-12-21
(Crawled : 09:00)
- biospace.com/
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
47.17%
|
O:
14.15%
H:
1.93%
C:
-16.25%
zynlonta
treatment
approval
therapeutics
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-27
(Crawled : 14:58)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
200.7%
|
O:
0.21%
H:
0.14%
C:
-0.05%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-27.4%
|
O:
-0.64%
H:
0.68%
C:
0.34%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-77.76%
|
O:
-0.05%
H:
1.0%
C:
-2.76%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-53.68%
|
O:
-0.67%
H:
2.09%
C:
-0.18%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-10.37%
|
O:
-0.54%
H:
0.65%
C:
0.49%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
55.8%
|
O:
-1.6%
H:
2.25%
C:
2.2%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-86.78%
|
O:
-0.47%
H:
1.53%
C:
-0.35%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-32.84%
|
O:
-0.41%
H:
0.14%
C:
-0.84%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-77.83%
|
O:
2.34%
H:
0.37%
C:
-1.69%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.19%
|
O:
-0.21%
H:
4.42%
C:
2.74%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
10.59%
|
O:
-0.12%
H:
0.58%
C:
-0.16%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
191.17%
|
O:
-1.17%
H:
2.55%
C:
0.59%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-22
(Crawled : 11:36)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
208.2%
|
O:
-0.0%
H:
1.02%
C:
0.51%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-26.83%
|
O:
-0.03%
H:
1.28%
C:
1.22%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-79.21%
|
O:
0.18%
H:
0.31%
C:
-2.26%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-56.75%
|
O:
-1.57%
H:
3.71%
C:
0.43%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-10.15%
|
O:
0.45%
H:
0.12%
C:
-0.6%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
54.21%
|
O:
-0.36%
H:
1.56%
C:
0.9%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-87.93%
|
O:
-0.53%
H:
0.38%
C:
-3.01%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-34.39%
|
O:
-0.39%
H:
0.11%
C:
-0.27%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.03%
|
O:
-1.49%
H:
2.0%
C:
-2.34%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.35%
|
O:
0.0%
H:
0.58%
C:
-3.46%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
5.85%
|
O:
-0.84%
H:
1.72%
C:
0.61%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
176.66%
|
O:
2.21%
H:
0.0%
C:
-4.87%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-16
(Crawled : 19:11)
- fda.gov
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-12
(Crawled : 00:01)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
207.94%
|
O:
-0.98%
H:
1.2%
C:
0.36%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-26.83%
|
O:
-0.15%
H:
1.19%
C:
0.66%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-80.87%
|
O:
-0.41%
H:
2.22%
C:
-1.07%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-53.98%
|
O:
0.03%
H:
1.08%
C:
-0.36%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-10.46%
|
O:
1.84%
H:
0.27%
C:
-0.38%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
55.09%
|
O:
-0.08%
H:
1.11%
C:
-1.02%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-88.77%
|
O:
0.1%
H:
1.48%
C:
-3.38%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-36.71%
|
O:
0.0%
H:
0.49%
C:
-1.05%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.98%
|
O:
-0.26%
H:
1.09%
C:
-0.52%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.41%
|
O:
5.35%
H:
0.7%
C:
-7.18%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
5.4%
|
O:
-0.21%
H:
0.05%
C:
-2.51%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
144.62%
|
O:
1.47%
H:
0.0%
C:
-5.79%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-09
(Crawled : 18:17)
- fda.gov
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-07-01
(Crawled : 13:13)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
218.63%
|
O:
-0.0%
H:
0.87%
C:
0.71%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-26.46%
|
O:
-0.6%
H:
0.48%
C:
0.21%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-80.78%
|
O:
-0.45%
H:
2.35%
C:
1.86%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-55.15%
|
O:
0.24%
H:
3.9%
C:
3.69%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-12.12%
|
O:
-0.27%
H:
0.36%
C:
0.08%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
61.16%
|
O:
-0.35%
H:
3.65%
C:
3.24%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-89.05%
|
O:
0.0%
H:
3.0%
C:
3.0%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-38.29%
|
O:
-0.05%
H:
0.49%
C:
-0.08%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.31%
|
O:
0.84%
H:
1.67%
C:
0.95%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.52%
|
O:
0.0%
H:
1.9%
C:
0.0%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
3.01%
|
O:
0.0%
H:
0.67%
C:
-0.34%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
127.54%
|
O:
1.21%
H:
0.0%
C:
-5.55%
cancer
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-06-16
(Crawled : 19:52)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
231.28%
|
O:
-0.22%
H:
1.28%
C:
0.88%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-26.57%
|
O:
0.16%
H:
0.21%
C:
-0.39%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-79.66%
|
O:
0.0%
H:
1.87%
C:
-0.04%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-57.63%
|
O:
0.0%
H:
5.48%
C:
5.2%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-13.38%
|
O:
-0.98%
H:
0.77%
C:
0.65%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
71.92%
|
O:
0.08%
H:
2.77%
C:
2.29%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-88.73%
|
O:
-0.8%
H:
6.08%
C:
5.53%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-37.54%
|
O:
-0.29%
H:
0.84%
C:
0.3%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.35%
|
O:
-0.45%
H:
1.02%
C:
0.23%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.54%
|
O:
1.35%
H:
5.34%
C:
1.67%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
5.9%
|
O:
-0.81%
H:
3.66%
C:
-1.58%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
119.55%
|
O:
-0.29%
H:
1.76%
C:
-2.5%
cancer
approval
FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
Published:
2021-06-11
(Crawled : 12:43)
- fda.gov
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-78.94%
|
O:
-0.18%
H:
2.19%
C:
0.14%
fda
granted
approval
grant
t-cell
ADC Therapeutics Shareholders Approve All Resolutions at the Annual General Meeting
Published:
2021-06-11
(Crawled : 12:00)
- biospace.com/
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-78.94%
|
O:
-0.18%
H:
2.19%
C:
0.14%
approval
Oncology (Cancer) / Hematologic Malignancies Approval Notifications
Published:
2021-06-09
(Crawled : 19:32)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
223.6%
|
O:
0.43%
H:
3.91%
C:
2.89%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-24.86%
|
O:
0.23%
H:
3.28%
C:
2.81%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-78.37%
|
O:
1.34%
H:
2.51%
C:
1.32%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-58.33%
|
O:
-0.14%
H:
5.67%
C:
3.3%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-12.32%
|
O:
1.21%
H:
1.07%
C:
0.67%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
72.49%
|
O:
-0.11%
H:
2.3%
C:
2.07%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-88.72%
|
O:
0.9%
H:
4.35%
C:
4.35%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-39.77%
|
O:
0.21%
H:
1.47%
C:
1.33%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-82.64%
|
O:
0.12%
H:
1.53%
C:
0.0%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.64%
|
O:
-3.25%
H:
2.87%
C:
-2.21%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
9.21%
|
O:
0.04%
H:
1.73%
C:
1.34%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
106.26%
|
O:
-0.28%
H:
1.38%
C:
-0.55%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-28
(Crawled : 18:31)
- fda.gov
ALNY
|
$145.9
0.08%
230K
|
Health Technology
|
Email alert
Add to watchlist
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
VSTM
|
$9.72
-0.21%
72K
|
Health Technology
|
Email alert
Add to watchlist
EXEL
|
$23.45
2.54%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$138.82
6.02%
130K
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$125.36
4.25%
710K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$274.12
0.81%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
A
|
$26.29
0.11%
14M
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.14
0.89%
350K
|
Health Technology
|
Email alert
Add to watchlist
AGIO
|
$32.76
8.44%
710K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.16
0.76%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-21
(Crawled : 18:33)
- fda.gov
PFE
|
News
A
|
$26.29
0.11%
14M
|
Health Technology
|
-34.55%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
266.53%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-26.66%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-77.15%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
News
|
$169.16
0.76%
2.7M
|
Health Technology
|
43.36%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-57.94%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.72
-0.21%
72K
|
Health Technology
|
205.33%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-14.37%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.14
0.89%
350K
|
Health Technology
|
-69.29%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
75.4%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-88.14%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-37.83%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$125.36
4.25%
710K
|
Health Technology
|
-69.67%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$23.45
2.54%
1.2M
|
Health Technology
|
-6.0%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
-5.05%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$138.82
6.02%
130K
|
Health Technology
|
-61.95%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
News
|
$274.12
0.81%
1.2M
|
Health Technology
|
7.93%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$145.9
0.08%
230K
|
Health Technology
|
4.06%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$32.76
8.44%
710K
|
Health Technology
|
-46.78%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-20
(Crawled : 18:26)
- fda.gov
PFE
|
News
A
|
$26.29
0.11%
14M
|
Health Technology
|
-34.55%
|
O:
0.22%
H:
0.97%
C:
-0.65%
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
266.53%
|
O:
0.24%
H:
0.96%
C:
-0.06%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-26.66%
|
O:
0.36%
H:
1.01%
C:
-0.28%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-77.15%
|
O:
2.54%
H:
0.48%
C:
-0.29%
ABBV
|
News
|
$169.16
0.76%
2.7M
|
Health Technology
|
43.36%
|
O:
0.35%
H:
0.65%
C:
-1.19%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-57.94%
|
O:
0.58%
H:
1.24%
C:
-1.66%
VSTM
|
$9.72
-0.21%
72K
|
Health Technology
|
205.33%
|
O:
0.63%
H:
2.49%
C:
-0.62%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-14.37%
|
O:
-0.43%
H:
0.2%
C:
0.02%
RIGL
|
$1.14
0.89%
350K
|
Health Technology
|
-69.29%
|
O:
0.82%
H:
1.08%
C:
-1.62%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
75.4%
|
O:
0.18%
H:
0.46%
C:
-1.44%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-88.14%
|
O:
0.31%
H:
1.15%
C:
-1.46%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-37.83%
|
O:
0.57%
H:
0.6%
C:
-1.46%
ILMN
|
$125.36
4.25%
710K
|
Health Technology
|
-69.67%
|
O:
0.33%
H:
2.2%
C:
0.21%
EXEL
|
$23.45
2.54%
1.2M
|
Health Technology
|
-6.0%
|
O:
0.08%
H:
1.64%
C:
0.45%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-83.08%
|
O:
1.04%
H:
0.0%
C:
-2.62%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.37%
|
O:
0.95%
H:
1.31%
C:
-2.81%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
-5.05%
|
O:
1.12%
H:
0.84%
C:
-0.08%
BGNE
|
$138.82
6.02%
130K
|
Health Technology
|
-61.95%
|
O:
0.1%
H:
1.6%
C:
0.88%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
115.45%
|
O:
1.19%
H:
1.71%
C:
-0.33%
AMGN
|
News
|
$274.12
0.81%
1.2M
|
Health Technology
|
7.93%
|
O:
0.71%
H:
0.14%
C:
-1.06%
ALNY
|
$145.9
0.08%
230K
|
Health Technology
|
4.06%
|
O:
0.38%
H:
1.01%
C:
-0.41%
AGIO
|
$32.76
8.44%
710K
|
Health Technology
|
-46.78%
|
O:
0.86%
H:
1.27%
C:
-0.24%
cancer
approval
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-05-05
(Crawled : 18:31)
- fda.gov
PFE
|
News
A
|
$26.29
0.11%
14M
|
Health Technology
|
-34.3%
|
O:
-3.73%
H:
1.95%
C:
1.85%
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
279.3%
|
O:
-0.65%
H:
1.33%
C:
1.22%
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
-24.03%
|
O:
-0.12%
H:
0.19%
C:
-0.22%
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-78.73%
|
O:
3.45%
H:
1.01%
C:
-0.66%
ABBV
|
News
|
$169.16
0.76%
2.7M
|
Health Technology
|
45.01%
|
O:
-0.67%
H:
1.03%
C:
0.94%
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
-46.43%
|
O:
-0.85%
H:
2.64%
C:
2.1%
VSTM
|
$9.72
-0.21%
72K
|
Health Technology
|
229.05%
|
O:
-2.03%
H:
0.82%
C:
-1.72%
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
-8.51%
|
O:
0.55%
H:
0.51%
C:
0.29%
RIGL
|
$1.14
0.89%
350K
|
Health Technology
|
-67.44%
|
O:
0.0%
H:
0.0%
C:
-6.05%
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
86.59%
|
O:
0.14%
H:
4.11%
C:
3.22%
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
-86.07%
|
O:
0.37%
H:
1.11%
C:
0.0%
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
-36.12%
|
O:
-0.09%
H:
1.99%
C:
1.35%
ILMN
|
$125.36
4.25%
710K
|
Health Technology
|
-68.22%
|
O:
-0.64%
H:
0.34%
C:
0.31%
EXEL
|
$23.45
2.54%
1.2M
|
Health Technology
|
-4.59%
|
O:
-0.88%
H:
0.34%
C:
-2.27%
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
-80.45%
|
O:
-0.27%
H:
0.0%
C:
-9.2%
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
-98.53%
|
O:
-0.34%
H:
0.86%
C:
-2.91%
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
-0.37%
|
O:
-0.26%
H:
2.88%
C:
2.72%
BGNE
|
$138.82
6.02%
130K
|
Health Technology
|
-57.13%
|
O:
0.14%
H:
3.67%
C:
2.67%
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
121.49%
|
O:
-0.3%
H:
0.15%
C:
-1.78%
AMGN
|
News
|
$274.12
0.81%
1.2M
|
Health Technology
|
9.05%
|
O:
-0.03%
H:
0.88%
C:
0.81%
ALNY
|
$145.9
0.08%
230K
|
Health Technology
|
9.89%
|
O:
-0.51%
H:
1.52%
C:
0.08%
AGIO
|
$32.76
8.44%
710K
|
Health Technology
|
-43.29%
|
O:
-0.45%
H:
4.45%
C:
3.9%
cancer
approval
ADC Therapeutics Announces FDA Approval of ZYNLONTA™ (loncastuximab tesirine-lpyl) in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Published:
2021-04-23
(Crawled : 23:00)
- biospace.com/
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
-80.82%
|
O:
1.84%
H:
8.65%
C:
-6.44%
fda
fda approval
approval
t-cell
Hematology/Oncology (Cancer) Approvals & Safety Notifications
Published:
2021-04-23
(Crawled : 18:42)
- fda.gov
LLY
|
News
|
$744.47
1.8%
1M
|
Health Technology
|
Email alert
Add to watchlist
RIGL
|
$1.14
0.89%
350K
|
Health Technology
|
Email alert
Add to watchlist
ILMN
|
$125.36
4.25%
710K
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$49.06
-0.16%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$138.82
6.02%
130K
|
Health Technology
|
Email alert
Add to watchlist
CLVS
|
$0.0812
-3.94%
|
Health Technology
|
Email alert
Add to watchlist
KPTI
|
$1.125
-0.44%
950K
|
Health Technology
|
Email alert
Add to watchlist
ALNY
|
$145.9
0.08%
230K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
A
|
$26.29
0.11%
14M
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$169.16
0.76%
2.7M
|
Health Technology
|
Email alert
Add to watchlist
AGIO
|
$32.76
8.44%
710K
|
Health Technology
|
Email alert
Add to watchlist
VSTM
|
$9.72
-0.21%
72K
|
Health Technology
|
Email alert
Add to watchlist
EPZM
|
$1.47
-1.34%
0.0%
|
Health Technology
|
Email alert
Add to watchlist
REGN
|
News
|
$910.71
1.17%
150K
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
YMAB
|
$15.6
2.9%
370K
|
Health Technology
|
Email alert
Add to watchlist
BPMC
|
$93.41
3.09%
500K
|
Health Technology
|
Email alert
Add to watchlist
EXEL
|
$23.45
2.54%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.72
1.21%
1.1M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$274.12
0.81%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
INCY
|
$52.02
0.19%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
cancer
approval
FDA grants accelerated approval to loncastuximab tesirine-lpyl for large B-cell lymphoma
Published:
2021-04-23
(Crawled : 18:42)
- fda.gov
ADCT
|
$5.039
7.67%
270K
|
Health Technology
|
Email alert
Add to watchlist
fda
approval
granted
grant
t-cell
Gainers vs Losers
85%
15%
Top 10 Gainers
MTTR
|
News
M
|
$4.56
162.07%
21M
|
AGBA
|
$2.99
139.2%
64M
|
Finance
CZOO
|
$8.67
73.75%
23M
|
EDBL
|
News
|
$6.47
72.07%
1.9M
|
MTC
|
$2.21
41.67%
5.6M
|
Technology Services
OPRT
|
News
|
$3.12
38.67%
11M
|
Finance
PALI
|
$6.59
33.67%
23M
|
Manufacturing
VNRX
|
$0.7989
33.15%
3.2M
|
Health Technology
BTCM
|
$3.51
30.0%
730K
|
Arts, Entertainment, and Recrea...
MLEC
|
$1.81
29.29%
2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.